Functional characterization of in vivo effector CD4+ and CD8+ T cell responses in acute Toxoplasmosis: An interplay of IFN-γ and cytolytic T cells

Vaccine

Volumn 28, Issue 13, 2010, Pages 2556-2564

  Jongert, Erik ^a   Lemiere, Arnaud ^a   Van Ginderachter, Jo ^b,c   De Craeye, Stéphane ^d   Huygen, Kris ^d   D'Souza, Sushila ^d  

^a PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

Cytotoxicity; Macrophages; Parasitic Protozoan infection; T cells; Toxoplasma gondii; Vaccination

Indexed keywords

DNA VACCINE; FAS LIGAND; GAMMA INTERFERON; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PARASITE ANTIGEN; PROTEIN GRA1; PROTEIN GRA7; PROTEIN ROP2; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DNA IMMUNIZATION; FEMALE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MOUSE; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; TACHYZOITE; TH1 CELL; TOXOPLASMOSIS;

ANIMALS; ANTIGENS, PROTOZOAN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; INTERFERON-GAMMA; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, INBRED C3H; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; TH1 CELLS; TOXOPLASMOSIS; VACCINES, DNA;

EID: 77649336179     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.01.031     Document Type: Article

References (60)

1. Lambert H., Vutova P.P., Adams W.C., Lore K., and Barragan A. The Toxoplasma gondii-shuttling function of dendritic cells is linked to the parasite genotype. Infect Immun 77 April (4) (2009) 1679-1688
2. Courret N., Darche S., Sonigo P., Milon G., Buzoni-Gatel D., and Tardieux I. CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood 107 January 1 (1) (2006) 309-316
3. Bierly A.L., Shufesky W.J., Sukhumavasi W., Morelli A.E., and Denkers E.Y. Dendritic cells expressing plasmacytoid marker PDCA-1 are Trojan horses during Toxoplasma gondii infection. J Immunol 181 December 15 (12) (2008) 8485-8491
4. Unno A., Suzuki K., Xuan X., Nishikawa Y., Kitoh K., and Takashima Y. Dissemination of extracellular and intracellular Toxoplasma gondii tachyzoites in the blood flow. Parasitol Int 57 December (4) (2008) 515-518
5. Luder C.G., Stanway R.R., Chaussepied M., Langsley G., and Heussler V.T. Intracellular survival of apicomplexan parasites and host cell modification. Int J Parasitol 39 January (2) (2009) 163-173
6. Luder C.G., Lang T., Beuerle B., and Gross U. Down-regulation of MHC class II molecules and inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii. Clin Exp Immunol 112 May (2) (1998) 308-316
7. Lang C., Algner M., Beinert N., Gross U., and Luder C.G. Diverse mechanisms employed by Toxoplasma gondii to inhibit IFN-gamma-induced major histocompatibility complex class II gene expression. Microbes Infect 8 July (8) (2006) 1994-2005
8. Luder C.G., Lang C., Giraldo-Velasquez M., Algner M., Gerdes J., and Gross U. Toxoplasma gondii inhibits MHC class II expression in neural antigen-presenting cells by down-regulating the class II transactivator CIITA. J Neuroimmunol 134 January (1-2) (2003) 12-24
9. Hippe D., Lytovchenko O., Schmitz I., and Luder C.G. Fas/CD95-mediated apoptosis of type II cells is blocked by Toxoplasma gondii primarily via interference with the mitochondrial amplification loop. Infect Immun 76 July (7) (2008) 2905-2912
10. Nash P.B., Purner M.B., Leon R.P., Clarke P., Duke R.C., and Curiel T.J. Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis. J Immunol 160 February 15 (4) (1998) 1824-1830
11. Hippe D., Gais A., Gross U., and Luder C.G. Modulation of caspase activation by Toxoplasma gondii. Methods Mol Biol 470 (2009) 275-288
12. Vutova P., Wirth M., Hippe D., Gross U., Schulze-Osthoff K., Schmitz I., et al. Toxoplasma gondii inhibits Fas/CD95-triggered cell death by inducing aberrant processing and degradation of caspase 8. Cell Microbiol 9 June (6) (2007) 1556-1570
13. El Kasmi K.C., Qualls J.E., Pesce J.T., Smith A.M., Thompson R.W., Henao-Tamayo M., et al. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat Immunol 9 December (12) (2008) 1399-1406
14. Luder C.G., Algner M., Lang C., Bleicher N., and Gross U. Reduced expression of the inducible nitric oxide synthase after infection with Toxoplasma gondii facilitates parasite replication in activated murine macrophages. Int J Parasitol 33 July 30 (8) (2003) 833-844
15. Seabra S.H., de Souza W., and Damatta R.A. Toxoplasma gondii exposes phosphatidylserine inducing a TGF-beta1 autocrine effect orchestrating macrophage evasion. Biochem Biophys Res Commun 324 November 12 (2) (2004) 744-752
16. Butcher B.A., Kim L., Johnson P.F., and Denkers E.Y. Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-kappa B. J Immunol 167 August 15 (4) (2001) 2193-2201
17. Zhao Y., Ferguson D.J., Wilson D.C., Howard J.C., Sibley L.D., and Yap G.S. Virulent Toxoplasma gondii evade immunity-related GTPase-mediated parasite vacuole disruption within primed macrophages. J Immunol 182 March 15 (6) (2009) 3775-3781
18. Persson E.K., Agnarson A.M., Lambert H., Hitziger N., Yagita H., Chambers B.J., et al. Death receptor ligation or exposure to perforin trigger rapid egress of the intracellular parasite Toxoplasma gondii. J Immunol 179 December 15 (12) (2007) 8357-8365
19. Persson C.M., Lambert H., Vutova P.P., Dellacasa-Lindberg I., Nederby J., Yagita H., et al. Transmission of Toxoplasma gondii from infected dendritic cells to natural killer cells. Infect Immun 77 March (3) (2009) 970-976
20. Yap G.S., and Sher A. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function. Immunobiology 201 December (2) (1999) 240-247
21. Denkers E.Y. T lymphocyte-dependent effector mechanisms of immunity to Toxoplasma gondii. Microbes Infect 1 July (9) (1999) 699-708
22. Denkers E.Y., and Gazzinelli R.T. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 11 October (4) (1998) 569-588
23. Montoya J.G., Lowe K.E., Clayberger C., Moody D., Do D., Remington J.S., et al. Human CD4+ and CD8+ T lymphocytes are both cytotoxic to Toxoplasma gondii-infected cells. Infect Immun 64 January (1) (1996) 176-181
24. Purner M.B., Berens R.L., Nash P.B., van Linden A., Ross E., Kruse C., et al. CD4-mediated and CD8-mediated cytotoxic and proliferative immune responses to Toxoplasma gondii in seropositive humans. Infect Immun 64 October (10) (1996) 4330-4338
25. Yano A., Aosai F., Yang T.H., He N., Mun H.S., Liu H., et al. Correlation between direct binding ability of synthetic T. gondii SAG1 peptides to HLA-A2 measured by a sensor for surface plasmon resonance and antigenicity of the peptides for T. gondii-infected cell-specific CTL. Biochem Biophys Res Commun 236 July 18 (2) (1997) 257-261
26. Brown D.M., Kamperschroer C., Dilzer A.M., Roberts D.M., and Swain S.L. IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cells. Cell Immunol 257 1-2 (2009) 69-79
27. Yang T.H., Aosai F., Norose K., Ueda M., and Yano A. Enhanced cytotoxicity of IFN-gamma-producing CD4+ cytotoxic T lymphocytes specific for T. gondii-infected human melanoma cells. J Immunol 154 January 1 (1) (1995) 290-298
28. Andrade R.M., Wessendarp M., and Subauste C.S. CD154 activates macrophage antimicrobial activity in the absence of IFN-gamma through a TNF-alpha-dependent mechanism. J Immunol 171 December 15 (12) (2003) 6750-6756
29. Rosenberg C., De Craeye S., Jongert E., Gargano N., Beghetto E., Del Porto P., et al. Induction of partial protection against infection with Toxoplasma gondii genotype II by DNA vaccination with recombinant chimeric tachyzoite antigens. Vaccine 27 April 21 (18) (2009) 2489-2498
30. Jongert E., Roberts C.W., Gargano N., Forster-Wald E., and Petersen E. Vaccines against Toxoplasma gondii: challenges and opportunities. Mem Inst Oswaldo Cruz 104 March (2) (2009) 252-266
31. Scorza T., D'Souza S., Laloup M., Dewit J., De Braekeleer J., Verschueren H., et al. A GRA1 DNA vaccine primes cytolytic CD8(+) T cells to control acute Toxoplasma gondii infection. Infect Immun 71 January (1) (2003) 309-316
32. Nielsen H.V., Lauemoller S.L., Christiansen L., Buus S., Fomsgaard A., and Petersen E. Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Infect Immun 67 December (12) (1999) 6358-6363
33. Aosai F., Mun H.S., Norose K., Chen M., Hata H., Kobayashi M., et al. Protective immunity induced by vaccination with SAG1 gene-transfected cells against Toxoplasma gondii-infection in mice. Microbiol Immunol 43 1 (1999) 87-91
34. Wang X., Kang H., Kikuchi T., and Suzuki Y. Gamma interferon production, but not perforin-mediated cytolytic activity, of T cells is required for prevention of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease. Infect Immun 72 August (8) (2004) 4432-4438
35. Denkers E.Y., Yap G., Scharton-Kersten T., Charest H., Butcher B.A., Caspar P., et al. Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. J Immunol 159 August 15 (4) (1997) 1903-1908
36. Jongert E., de Craeye S., Dewit J., and Huygen K. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii. Parasite Immunol 29 September (9) (2007) 445-453
37. Vercammen M., Scorza T., Huygen K., De Braekeleer J., Diet R., Jacobs D., et al. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infect Immun 68 January (1) (2000) 38-45
38. Monner D.A., and Denker B. Characterization of clonally derived, spontaneously transformed bone marrow macrophage cell lines from lipopolysaccharide hyporesponsive LPS(d) and normal LPS(n) mice. J Leukoc Biol 61 April (4) (1997) 469-480
39. Sallusto F., Lenig D., Forster R., Lipp M., and Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401 October 14 (6754) (1999) 708-712
40. Makedonas G., Banerjee P.P., Pandey R., Hersperger A.R., Sanborn K.B., Hardy G.A., et al. Rapid up-regulation and granule-independent transport of perforin to the immunological synapse define a novel mechanism of antigen-specific CD8+ T cell cytotoxic activity. J Immunol 182 May 1 (9) (2009) 5560-5569
41. Betts M.R., Brenchley J.M., Price D.A., De Rosa S.C., Douek D.C., Roederer M., et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281 October 1 (1-2) (2003) 65-78
42. Suni M.A., Maino V.C., and Maecker H.T. Ex vivo analysis of T-cell function. Curr Opin Immunol 17 August (4) (2005) 434-440
43. Jongert E., Melkebeek V., De Craeye S., Dewit J., Verhelst D., and Cox E. An enhanced GRA1-GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in pigs. Vaccine 26 February 20 (8) (2008) 1025-1031
44. Zhao Y.O., Khaminets A., Hunn J.P., and Howard J.C. Disruption of the Toxoplasma gondii parasitophorous vacuole by IFNgamma-inducible immunity-related GTPases (IRG proteins) triggers necrotic cell death. PLoS Pathog 5 February (2) (2009) e1000288
45. Regner M., Pavlinovic L., Koskinen A., Young N., Trapani J.A., and Mullbacher A. Cutting edge: rapid and efficient in vivo cytotoxicity by cytotoxic T cells is independent of granzymes A and B. J Immunol 183 July 1 (1) (2009) 37-40
46. Harari A., Enders F.B., Cellerai C., Bart P.A., and Pantaleo G. Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure. J Virol 83 April (7) (2009) 2862-2871
47. Wolint P., Betts M.R., Koup R.A., and Oxenius A. Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells. J Exp Med 199 April 5 (7) (2004) 925-936
48. Meiraz A., Garber O.G., Harari S., Hassin D., and Berke G. Switch from perforin-expressing to perforin-deficient CD8(+) T cells accounts for two distinct types of effector cytotoxic T lymphocytes in vivo. Immunology 128 September (1) (2009) 69-82
49. He J.S., and Ostergaard H.L. CTLs contain and use intracellular stores of FasL distinct from cytolytic granules. J Immunol 179 August 15 (4) (2007) 2339-2348
50. Gazzinelli R.T., Hakim F.T., Hieny S., Shearer G.M., and Sher A. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol 146 January 1 (1) (1991) 286-292
51. Jordan K.A., Wilson E.H., Tait E.D., Fox B.A., Roos D.S., Bzik D.J., et al. Kinetics and phenotype of vaccine-induced CD8+ T-cell responses to Toxoplasma gondii. Infect Immun 77 September (9) (2009) 3894-3901
52. Fox B.A., and Bzik D.J. De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii. Nature 415 February 21 (6874) (2002) 926-929
53. Subauste C.S., Koniaris A.H., and Remington J.S. Murine CD8+ cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells. J Immunol 147 December 1 (11) (1991) 3955-3959
54. Hakim F.T., Gazzinelli R.T., Denkers E., Hieny S., Shearer G.M., and Sher A. CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. J Immunol 147 October 1 (7) (1991) 2310-2316
55. Yamashita K., Yui K., Ueda M., and Yano A. Cytotoxic T-lymphocyte-mediated lysis of Toxoplasma gondii-infected target cells does not lead to death of intracellular parasites. Infect Immun 66 October (10) (1998) 4651-4655
56. Ling Y.M., Shaw M.H., Ayala C., Coppens I., Taylor G.A., Ferguson D.J., et al. Vacuolar and plasma membrane stripping and autophagic elimination of Toxoplasma gondii in primed effector macrophages. J Exp Med 203 September 4 (9) (2006) 2063-2071
57. Melzer T., Duffy A., Weiss L.M., and Halonen S.K. The gamma interferon (IFN-gamma)-inducible GTP-binding protein IGTP is necessary for toxoplasma vacuolar disruption and induces parasite egression in IFN-gamma-stimulated astrocytes. Infect Immun 76 November (11) (2008) 4883-4894
58. Halonen S.K. Role of autophagy in the host defense against Toxoplasma gondii in astrocytes. Autophagy 5 February (2) (2009) 268-269
59. Blanchard N., Gonzalez F., Schaeffer M., Joncker N.T., Cheng T., Shastri A.J., et al. Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum. Nat Immunol 9 August (8) (2008) 937-944
60. Rutkowski M.R., Ho O., and Green W.R. Defining the mechanism(s) of protection by cytolytic CD8 T cells against a cryptic epitope derived from a retroviral alternative reading frame. Virology 390 August 1 (2) (2009) 228-238